Consensus Humana Inc.

Equities

HUM

US4448591028

Market Closed - Nyse Other stock markets 04:00:02 2024-04-24 pm EDT			5-day change	1st Jan Change
316 ^USD	-3.66%		-2.31%	-30.98%

Apr. 24	Molina Healthcare beats profit estimates aided by higher premiums	RE
Apr. 24	Sector Update: Health Care Stocks Slipping Late Afternoon	MT

Evolution of the average Target Price on Humana Inc.

Price target over the last 5 years

History of analyst recommendation changes

b7f4f4735e01b659d.cLpKz9ozV8mddXxOmAP_37mXSo_nUfZW3Txz6-Iz2Rc.KsI-_7FSOKjFLxR59y7IsPijLeOeMsAQiHIsgqlFsEZDgxKFmGFnmcsPPQ~f812710eedd4f55dd1be91eba16b88ff

Analyst Recommendations on Humana Inc.

TD Cowen Lowers Humana Price Target to $396 from $427	Apr. 24	MT
Mizuho Adjusts Price Target on Humana to $385 From $400	Apr. 22	MT
Jefferies Lowers Humana Price Target to $381 from $411	Apr. 22	MT
Zacks Upgrades Humana to Neutral From Underperform	Apr. 17	MT
Truist Securities Adjusts Price Target on Humana to $355 From $400	Apr. 15	MT
Wells Fargo Cuts Price Target on Humana to $350 From $413, Maintains Overweight Rating	Apr. 08	MT
Goldman Sachs Cuts Price Target on Humana to $385 From $450, Maintains Buy Rating	Apr. 03	MT
UBS Cuts Humana's Price Target to $334 From $370, Maintains Neutral Rating	Apr. 02	MT
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman...	Apr. 02
Raymond James Starts Humana With Market Perform Rating	Mar. 22	MT
Argus Downgrades Humana to Hold From Buy	Mar. 13	MT
That's good enough for investors	Feb. 06
ANALYST RECOMMENDATIONS : Chevron, McDonald's, Palantir, Sainsbury, Tesla...	Feb. 06
Wells Fargo Adjusts Price Target on Humana to $413 From $465, Keeps Overweight Rating	Jan. 30	MT
Goldman Sachs Cuts Price Target on Humana to $450 From $515, Keeps Buy Rating	Jan. 29	MT
Nephron Research Cuts Humana Price Target to $400 From $648, Maintains Buy Rating	Jan. 26	MT
Stephens Adjusts Humana Price Target to $430 From $550, Maintains Overweight Rating	Jan. 26	MT
Truist Securities Adjusts Humana Price Target to $400 From $550, Maintains Hold Rating	Jan. 26	MT
Jefferies Cuts Humana Price Target to $411 From $470, Maintains Buy Rating	Jan. 26	MT
Cantor Fitzgerald Downgrades Humana to Neutral From Overweight, Cuts Price Target to $391 From $597	Jan. 26	MT
UBS Downgrades Humana to Neutral From Buy, Adjusts Price Target to $370 From $530	Jan. 26	MT
Deutsche Bank Downgrades Humana to Hold From Buy, Trims Price Target to $359 From $360	Jan. 26	MT
Goldman Sachs Cuts Price Target on Humana to $450 From $515, Maintains Buy Rating	Jan. 26	MT
Inflation is just the icing on the cake	Jan. 26
Oppenheimer Adjusts Humana Price Target to $415 From $630, Maintains Outperform Rating	Jan. 26	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

316 USD

Average target price

387.2 USD

Spread / Average Target

+22.54%

High Price Target

550 USD

Spread / Highest target

+74.06%

Low Price Target

326 USD

Spread / Lowest Target

+3.17%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Humana Inc.

TD Cowen
Jefferies & Co.
Mizuho Securities
Zacks Investment Research
Truist Securities
Wells Fargo Securities
Goldman Sachs
UBS
Raymond James
Argus
Nephron Research
Stephens Inc.
Cantor Fitzgerald
Deutsche Bank Securities
Oppenheimer
RBC Capital Markets
JPMorgan Chase
Bernstein
Morgan Stanley
SVB Securities LLC
Cowen
Credit Suisse
Loop Capital
BMO Capital
Barclays
SVB Leerink
Citigroup
Seaport Global Securities

Ratings for Humana Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar